Galaxy Therapeutics Appoints Neurovascular Industry Expert, Dr. Michael Alexander, as Chief Medical Officer

Newest Addition in Line with the Company's Stated Goal of Expanding its Clinical and Scientific Teams as it Progresses Development and Ultimate Commercialization of its SEAL™ Device to Treat Brain Aneurysms MILPITAS, Calif. , June 18, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately...

Read More